We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Monoclonal Antibodies: Making Cancer a Target

Video   Sep 25, 2019 | Taken from the Cancer Research Institute

 

Monoclonal antibodies, like the drugs Avastin (bevacizumab), Herceptin (trastuzumab), and Rituxin (rituximab), are effective in treating a wide range of cancer types such as lung cancer, breast cancer, lymphoma, and others. By binding to cancer antigens, monoclonal antibodies mark the cells for destruction by the immune system. Clinical trials of more monoclonal antibodies for additional cancer types are ongoing.

 
More Information
 
 
 

Recommended Videos

Harnessing the Power of Immunology to Heal Ourselves

Video

How does our immune system work and how can it be manipulated to to develop new ways of healing our bodies?

WATCH NOW

New Class of Painkiller Found in the Mud

Video

A decade-old mud sample has revealed a potential new class of painkillers that are as potent as opioids.

WATCH NOW

Cell Fates - Division, Senescence and Death

Video

In this video, learn about the fates of a cell.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE